Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Long COVID Clinical Trials

11 recruiting trials for Long COVID. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
11
Total Trials
11
Recruiting Now
1
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT04806620

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from...

Sponsor: Brain Inflammation CollaborativeEnrolling: 100001 location
RECRUITINGNCT06928506

Effect of Hi-OxSR for the Treatment of Post COVID Condition

The RECLAIM study platform will be used to explore whether the use of the Hi-OxSR device improves the symptoms of post covid cognitive dysfunction. Carbon dioxide (CO2) has been...

Sponsor: University Health Network, TorontoEnrolling: 1203 locations
RECRUITINGNCT06932237

Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans

Mental health symptoms, including cognitive impairment ("brain fog"), following COVID-19 are of great concern to Veterans. This research seeks to advance understanding of the...

Sponsor: VA Office of Research and DevelopmentEnrolling: 2002 locations
RECRUITINGNCT06456502

Effectiveness of Non-invasive Neuromodulation in Patients With Long-COVID

Sleep quality and duration are critical to cognitive, emotional and physical well-being, and poor sleep quality has been associated with an increased risk of cognitive,...

Sponsor: Universidad Rey Juan CarlosEnrolling: 441 location
RECRUITINGNCT06452095

Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy...

The RECLAIM study platform will be used to explore whether the use of Hyperbaric Oxygen therapy (HBOT) improves the symptoms of post covid cognitive dysfunction. Hyperbaric...

Sponsor: University Health Network, TorontoEnrolling: 1201 location
RECRUITINGPhase 2NCT06766825

Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC)

The study aims to prove that plitidepsin could be an efficacious, safe, and well-tolerated therapy for PCC. To this end, we will perform a randomized, double-blind study comparing...

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaEnrolling: 901 location
RECRUITINGNCT07435805

Long-Term Health Effects of Previous COVID-19 in Patients Undergoing Preoperative Anesthesia Evaluation

The COVID-19 pandemic has resulted in persistent health problems in a significant proportion of individuals after recovery from the acute infection. These long-term...

Sponsor: Elazıg Fethi Sekin Sehir HastanesiEnrolling: 4001 location
RECRUITINGPhase 3NCT06928272

Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

The Long-Covid (LC)-Revitalize clinical study is testing repurposed drug treatments for Long Covid, involving adult participants from Brazil, Canada, Italy, Uganda, the United...

Sponsor: Douglas D. FraserEnrolling: 3489 locations
RECRUITINGNCT06311435

Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19

The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of specific blood RNA from patients...

Sponsor: MaxWell Clinic, PLCEnrolling: 2243 locations
RECRUITINGPhase 2 / Phase 3NCT05926505

Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome

The PRECISION is a proof-of-concept, phase II randomized clinical trial aiming to evaluate the efficacy and safety of anakinra in patients with Post-Acute COVID Syndrome (PACS) of...

Sponsor: Hellenic Institute for the Study of SepsisEnrolling: 18220 locations
RECRUITINGNCT06614309

Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog

This study aims to assess the effects of both acute and chronic exposures to hypoxia and hypercapnia in patients with Long COVID syndrome.

Sponsor: Mayo ClinicEnrolling: 451 location

Frequently Asked Questions

There are currently 11 clinical trials for Long COVID, with 11 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Long COVID, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Long COVID, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.